mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
9e-05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0002 |